D-1047-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1047-2019 was initiated by American Health Packaging on Mar 6, 2019 and is designated Class II. Reason for recall: CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 3337 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2019
Initiation Date
Mar 6, 2019
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3337 cartons

Product description

Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 (Individual Dose NDC:60687-139-11, Carton NDC#: 60687-139-01)

Reason for recall

CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot 179791, Mar 2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1047-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1047-2019. Report a data issue: hello@regdatalab.com.